Singapore markets closed

Elanco Animal Health Incorporated (ELAN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
17.20+0.31 (+1.84%)
At close: 04:00PM EDT
17.25 +0.05 (+0.29%)
Pre-market: 08:45AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.50B
Enterprise value 13.92B
Trailing P/E N/A
Forward P/E 18.12
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.94
Price/book (mrq)1.40
Enterprise value/revenue 3.19
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 3100.70%
S&P500 52-week change 326.43%
52-week high 317.43
52-week low 37.88
50-day moving average 315.00
200-day moving average 313.19

Share statistics

Avg vol (3-month) 34.4M
Avg vol (10-day) 36.06M
Shares outstanding 5494.18M
Implied shares outstanding 6494.18M
Float 8491.72M
% held by insiders 10.65%
% held by institutions 198.47%
Shares short (15 Apr 2024) 415.52M
Short ratio (15 Apr 2024) 44.27
Short % of float (15 Apr 2024) 45.04%
Short % of shares outstanding (15 Apr 2024) 43.14%
Shares short (prior month 15 Mar 2024) 412.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -29.83%
Operating margin (ttm)11.04%

Management effectiveness

Return on assets (ttm)1.03%
Return on equity (ttm)-19.24%

Income statement

Revenue (ttm)4.37B
Revenue per share (ttm)8.86
Quarterly revenue growth (yoy)-4.10%
Gross profit (ttm)N/A
EBITDA 878M
Net income avi to common (ttm)-1.3B
Diluted EPS (ttm)-2.65
Quarterly earnings growth (yoy)-68.90%

Balance sheet

Total cash (mrq)345M
Total cash per share (mrq)0.7
Total debt (mrq)5.77B
Total debt/equity (mrq)95.20%
Current ratio (mrq)3.29
Book value per share (mrq)12.26

Cash flow statement

Operating cash flow (ttm)418M
Levered free cash flow (ttm)84.75M